Hong Shen

796 total citations
16 papers, 630 citations indexed

About

Hong Shen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hong Shen has authored 16 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Hong Shen's work include TGF-β signaling in diseases (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Autophagy in Disease and Therapy (2 papers). Hong Shen is often cited by papers focused on TGF-β signaling in diseases (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Autophagy in Disease and Therapy (2 papers). Hong Shen collaborates with scholars based in China, United States and Canada. Hong Shen's co-authors include Shan Zeng, Yaojie Fu, Shanshan Liu, Ying Han, Cao Guo, Ganlu Deng, Ling Yin, Changjing Cai, Jia Chen and Hong Zhu and has published in prestigious journals such as Advanced Science, Journal of Cellular Physiology and Cancer Letters.

In The Last Decade

Hong Shen

16 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Shen China 10 312 203 168 151 143 16 630
Tongyue Zhang China 16 418 1.3× 189 0.9× 264 1.6× 120 0.8× 136 1.0× 36 736
Eleonora Lai Italy 14 205 0.7× 315 1.6× 154 0.9× 145 1.0× 93 0.7× 46 572
Serena De Matteis Italy 13 282 0.9× 162 0.8× 178 1.1× 81 0.5× 119 0.8× 34 658
Xiaofeng Li China 13 291 0.9× 247 1.2× 176 1.0× 143 0.9× 58 0.4× 57 683
Melissa M. Johnson United States 15 344 1.1× 232 1.1× 121 0.7× 103 0.7× 175 1.2× 36 756
Kezhi Li China 14 228 0.7× 194 1.0× 179 1.1× 117 0.8× 90 0.6× 47 526
Yiqun Zhang United States 17 288 0.9× 346 1.7× 143 0.9× 138 0.9× 102 0.7× 36 805
Suihai Wang China 15 482 1.5× 133 0.7× 250 1.5× 74 0.5× 113 0.8× 25 745
Shuzhen Chen China 10 234 0.8× 109 0.5× 147 0.9× 77 0.5× 73 0.5× 13 481
Isett Laux United States 11 331 1.1× 225 1.1× 127 0.8× 137 0.9× 211 1.5× 14 715

Countries citing papers authored by Hong Shen

Since Specialization
Citations

This map shows the geographic impact of Hong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Shen more than expected).

Fields of papers citing papers by Hong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Shen. The network helps show where Hong Shen may publish in the future.

Co-authorship network of co-authors of Hong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Shen. A scholar is included among the top collaborators of Hong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Shen. Hong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Han, Ying, Xinyue Xu, Yinghui Peng, et al.. (2025). CircFLNB upregulated by chemotherapy via alternative splicing suppresses the progression of colorectal cancer. Cancer Letters. 631. 217932–217932. 1 indexed citations
2.
3.
Gao, Yan, Yinghui Peng, Yulai Zhou, et al.. (2025). Mitochondrial gene SLC25A24 regulated anti-tumor immunity and inhibited the proliferation and metastasis of colorectal cancer by PKG1-dependent cGMP/PKG1 pathway. International Immunopharmacology. 157. 114664–114664. 1 indexed citations
4.
Cai, Changjing, Xiangyang Zhang, Yihan Liu, et al.. (2021). Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality. Gut Pathogens. 13(1). 70–70. 16 indexed citations
5.
Han, Ying, et al.. (2021). In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity. Cell & Bioscience. 11(1). 48–48. 8 indexed citations
6.
Li, Qian, et al.. (2021). Upregulation of long non‑coding RNA MYU promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells. Experimental and Therapeutic Medicine. 21(6). 644–644. 2 indexed citations
7.
Chen, Yihong, Ganlu Deng, Yaojie Fu, et al.. (2020). <p>FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer</p>. OncoTargets and Therapy. Volume 13. 1625–1635. 40 indexed citations
8.
Fu, Yaojie, Shanshan Liu, Shan Zeng, & Hong Shen. (2019). From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 396–396. 301 indexed citations
9.
Yin, Ling, Yihong Chen, You Zhou, et al.. (2019). Increased long noncoding RNA LASP1‐AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1. Journal of Cellular Physiology. 234(8). 13493–13509. 14 indexed citations
10.
Deng, Ganlu, Shan Zeng, Qingqing Luo, et al.. (2018). BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation. Journal of Experimental & Clinical Cancer Research. 37(1). 156–156. 41 indexed citations
11.
Ma, Junli, Shan Zeng, Yan Zhang, et al.. (2017). BMP4 enhances hepatocellular carcinoma proliferation by promoting cell cycle progression via ID2/CDKN1B signaling. Molecular Carcinogenesis. 56(10). 2279–2289. 28 indexed citations
12.
Shen, Hong, Jinlin Huang, Haichao Wang, et al.. (2014). Intraperitoneal Administration of Fetuin-A Attenuates d-Galactosamine/Lipopolysaccharide-Induced Liver Failure in Mouse. Digestive Diseases and Sciences. 59(8). 1789–1797. 15 indexed citations
13.
Zeng, Shan, Jia Chen, & Hong Shen. (2010). Controlling of bone morphogenetic protein signaling. Cellular Signalling. 22(6). 888–893. 21 indexed citations
14.
15.
Zeng, Shan, Liangfang Shen, Xiaoping Wan, et al.. (2007). A Short‐Term Long‐Chain Triglycerides Infusion Has No Influence on Immune Function of Adult Patients Undergoing Gastrointestinal Surgery. Journal of Parenteral and Enteral Nutrition. 31(3). 167–172. 7 indexed citations
16.
Pei, Haiping, Hong Zhu, Shan Zeng, et al.. (2007). Proteome Analysis and Tissue Microarray for Profiling Protein Markers Associated with Lymph Node Metastasis in Colorectal Cancer. Journal of Proteome Research. 6(7). 2495–2501. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tongyue Zhang Breakdown of academic impact, for papers by Eleonora Lai Breakdown of academic impact, for papers by Serena De Matteis Breakdown of academic impact, for papers by Xiaofeng Li Breakdown of academic impact, for papers by Melissa M. Johnson Breakdown of academic impact, for papers by Kezhi Li Breakdown of academic impact, for papers by Yiqun Zhang Breakdown of academic impact, for papers by Suihai Wang Breakdown of academic impact, for papers by Shuzhen Chen Breakdown of academic impact, for papers by Isett Laux
Rankless by CCL
2026